These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
769 related items for PubMed ID: 27619680
1. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N, Yu JW, Ni XC, Wu JG, Wang SL, Jiang BJ. Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [Abstract] [Full Text] [Related]
2. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer. Lee SO, Yang X, Duan S, Tsai Y, Strojny LR, Keng P, Chen Y. Oncotarget; 2016 Feb 09; 7(6):6626-38. PubMed ID: 26675547 [Abstract] [Full Text] [Related]
3. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells. Lu R, Zhao G, Yang Y, Jiang Z, Cai J, Hu H. Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819864311. PubMed ID: 31405336 [Abstract] [Full Text] [Related]
4. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells. Zhu Y, Yu J, Wang S, Lu R, Wu J, Jiang B. Oncol Rep; 2014 Dec 01; 32(6):2437-44. PubMed ID: 25230779 [Abstract] [Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury. Li J, Zhou J, Zhang D, Song Y, She J, Bai C. J Cell Mol Med; 2015 Oct 01; 19(10):2341-51. PubMed ID: 26177266 [Abstract] [Full Text] [Related]
6. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis. Chen P, Huang H, Wu J, Lu R, Wu Y, Jiang X, Yuan Q, Chen Y. Mol Carcinog; 2015 Dec 01; 54(12):1678-85. PubMed ID: 25408361 [Abstract] [Full Text] [Related]
7. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer. Zhou JY, Chen M, Ma L, Wang X, Chen YG, Liu SL. Oncotarget; 2016 Feb 16; 7(7):7657-66. PubMed ID: 26840024 [Abstract] [Full Text] [Related]
8. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y, Wu D. J Cell Biochem; 2014 Jun 16; 115(6):1112-21. PubMed ID: 24356998 [Abstract] [Full Text] [Related]
12. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK. Zhai B, Zhang X, Sun B, Cao L, Zhao L, Li J, Ge N, Chen L, Qian H, Yin Z. Tumour Biol; 2016 Jun 16; 37(6):8047-55. PubMed ID: 26711788 [Abstract] [Full Text] [Related]
15. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway. Zhang X, Shao J, Li X, Cui L, Tan Z. Oncol Rep; 2019 Feb 16; 41(2):1067-1074. PubMed ID: 30483804 [Abstract] [Full Text] [Related]
17. Girdin maintains the stemness of glioblastoma stem cells. Natsume A, Kato T, Kinjo S, Enomoto A, Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi M, Wakabayashi T. Oncogene; 2012 May 31; 31(22):2715-24. PubMed ID: 22020337 [Abstract] [Full Text] [Related]
18. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways. Wang D, Xin Y, Tian Y, Li W, Sun D, Yang Y. Exp Cell Res; 2017 Mar 01; 352(1):34-44. PubMed ID: 28132880 [Abstract] [Full Text] [Related]
19. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway. Wang G, Lu M, Yao Y, Wang J, Li J. Eur J Pharmacol; 2017 Nov 05; 814():207-215. PubMed ID: 28847482 [Abstract] [Full Text] [Related]
20. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L. Mol Carcinog; 2017 Dec 05; 56(12):2669-2680. PubMed ID: 28767179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]